Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Extracellular vesicles, including exosomes from certain cells, can stimulate hair growth.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Stem cell therapy shows promise for hair loss treatment, but more research is needed to confirm its effectiveness.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Sodium valproate caused vomiting in 20% of children under 2 years old, with other side effects like hair loss and loss of appetite also noted.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

New ginseng compounds may help treat degenerative diseases.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Effective sunscreen formulations can reduce skin absorption and enhance protection.

Hydrogel scaffolds can help wounds heal better and grow hair.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Hair follicles prevent NK cell attacks to avoid hair loss.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Stress may trigger hair loss by affecting immune protection in hair follicles.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.